Entero Healthcare Solutions saw Surbhi Singh, acting as trustee for the Prasad Uno Family Trust, disclose the sale of 21.30 lakh shares via stock exchange mechanisms.

The transaction, executed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, comprised a bulk deal and a block deal.

Transaction details

The acquirer sold a total of 21.30 lakh shares, reducing their holding significantly. The sales occurred over two days in September 2026.

Shareholding pattern change

Prior to the sale, the trust held 34,55,420 shares, representing 7.94% of the total share capital. Following the disposal, the total holding dropped to 13,25,420 shares.

The disclosure confirmed that the acquirer does not belong to the promoter or promoter group of the target company. The total equity share capital of Entero Healthcare Solutions remains ₹43.52 crore, comprising 4,35,23,072 equity shares of face value ₹10 each.

Entero Healthcare Solutions Ltd Entero Healthcare Solutions disclosed on September 12, 2026, that its subsidiary ACE Cardiopathy Solutions Private Limited was levied a monetary penalty by the GST Authority in Uttar Pradesh.

The Office of Assistant Commissioner (Uttar Pradesh) imposed a penalty of ₹12,91,728 on ACE Cardiopathy for non-generation of E-Invoice. The order was received by the company on September 11, 2026.

Penalty Details and Payment

The company stated that the penalty amount has been paid under protest. This payment was made to secure the immediate release of a vehicle and to avoid further demurrage charges and operational losses associated with the detention of the asset.

Financial Impact and Next Steps

Entero Healthcare described the matter as pertaining to a subsidiary and noted that the amount involved is not material to the consolidated financial position, operations, or other activities of the listed entity.

The company indicated that ACE Cardiopathy shall pursue recovery or refund of the amount paid under protest through appropriate remedies available under the GST law. Necessary steps in this regard will be initiated in due course.

This disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, read with Part A of Schedule III thereto.